Australia's most trusted
source of pharma news
Posted 25 January 2022 PM
Novartis earned the most from the Pharmaceutical Benefits Scheme for the financial year ending 2021, the PBS Expenditure and Prescriptions Report reveals.
Overall, the top 21 pharmas accounted for $10.01 billion of PBS spending in 2020-2021, or about 73 per cent of total spending.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.